podophyllotoxin has been researched along with Carcinoma, Transitional Cell in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujita, K; Murayama, T; Sayama, T | 1 |
Oliver, RT; Ponder, BA | 1 |
Dalesio, O; de Pauw, M; Denis, L; Robinson, M; Schulman, CC; Smith, P; Sylvester, R; Viggiano, G | 1 |
Elson, P; Khandekar, JD; Qazi, R | 1 |
Soloway, MS | 1 |
Martino, C; Soloway, MS | 1 |
Aso, Y; Fukushima, M; Matsuura, O; Naide, Y; Ohshima, S; Ono, Y; Ota, K; Suzuki, K; Tajima, A; Ushiyama, T | 1 |
Berenberg, J; Blumenstein, BA; Bukowski, RM; Johnson, K; O'Bryan, RM; Oishi, N; Quagliana, J; Rivkin, SE; Saiers, JH; Stephens, RL | 1 |
Biondo, F; Caramia, G; Gebbia, N; Pavone-Macaluso, M; Rausa, L; Rizzo, FP | 1 |
1 review(s) available for podophyllotoxin and Carcinoma, Transitional Cell
Article | Year |
---|---|
Intravesical and systemic chemotherapy of murine bladder cancer.
Topics: Animals; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Ethoglucid; FANFT; Female; Fluorouracil; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Podophyllotoxin; Thiotepa; Urinary Bladder Neoplasms | 1977 |
1 trial(s) available for podophyllotoxin and Carcinoma, Transitional Cell
Article | Year |
---|---|
Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM26) and TUR alone.
Topics: Carcinoma, Transitional Cell; Clinical Trials as Topic; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Podophyllotoxin; Random Allocation; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1982 |
7 other study(ies) available for podophyllotoxin and Carcinoma, Transitional Cell
Article | Year |
---|---|
[Effect of etoposide for pulmonary metastases from urogenital tract cancer].
Topics: Adenocarcinoma; Administration, Oral; Aged; Carcinoma, Transitional Cell; Etoposide; Humans; Infusions, Parenteral; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Prostatic Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms | 1984 |
Phase II study of VP 16-213 (etoposide) in metastatic transitional cell urothelial cancer.
Topics: Adult; Aged; Carcinoma, Transitional Cell; Drug Evaluation; Etoposide; Humans; Infusions, Parenteral; Middle Aged; Podophyllotoxin; Urinary Bladder Neoplasms | 1984 |
Phase II evaluation of VM-26 in patients with metastatic transitional cell carcinoma of the urinary tract: an Eastern Cooperative Oncology Group study.
Topics: Aged; Carcinoma, Transitional Cell; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Teniposide; Urologic Neoplasms | 1982 |
Prophylaxis of bladder tumor implantation. Intravesical and systemic chemotherapy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Disease Models, Animal; Doxorubicin; Female; Methylnitrosourea; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Podophyllotoxin; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1976 |
[Use of VM-26 as a single agent in the treatment of transitional cell carcinoma of the urinary tract].
Topics: Adult; Aged; Carcinoma, Transitional Cell; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Podophyllotoxin; Teniposide; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1988 |
Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.
Topics: Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Female; Humans; Kidney Neoplasms; Male; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1987 |
Experimental techniques for testing the sensitivity of bladder tumours to antineoplastic drugs.
Topics: Administration, Topical; Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Nucleus; Cricetinae; Cytotoxicity Tests, Immunologic; Daunorubicin; Demecolcine; DNA, Neoplasm; Doxorubicin; Drug Resistance; Fluorescence; Glycosides; Humans; Melphalan; Microscopy, Fluorescence; Neoplasm Transplantation; Oxidoreductases; Podophyllotoxin; Protein Biosynthesis; Thiophenes; Thiotepa; Transplantation, Heterologous; Urinary Bladder Neoplasms | 1973 |